Follow
Jonathan D. Moore
Jonathan D. Moore
Horizon Discovery
Verified email at horizondiscovery.com
Title
Cited by
Cited by
Year
Hysteresis drives cell-cycle transitions in Xenopus laevis egg extracts
W Sha, J Moore, K Chen, AD Lassaletta, CS Yi, JJ Tyson, JC Sible
Proc Natl Acad Sci 100 (3), 975, 2003
5652003
Control of cyclin B1 localization through regulated binding of the nuclear export factor CRM1
J Yang, ESG Bardes, JD Moore, J Brennan, MA Powers, S Kornbluth
Genes & development 12 (14), 2131-2143, 1998
4441998
Nuclear import of Cdk/cyclin complexes: identification of distinct mechanisms for import of Cdk2/cyclin E and Cdc2/cyclin B1
JD Moore, J Yang, R Truant, S Kornbluth
The Journal of cell biology 144 (2), 213-224, 1999
2871999
Kinesin proteins: A phylum of motors for microtubule‐based motility
JD Moore, SA Endow
Bioessays 18 (3), 207-219, 1996
2181996
Unmasking the S-phase-promoting potential of cyclin B1
JD Moore, JA Kirk, T Hunt
Science 300 (5621), 987-990, 2003
1622003
The Ran‐GTPase and cell‐cycle control
JD Moore
Bioessays 23 (1), 77-85, 2001
1392001
Pin1 inhibitors: Pitfalls, progress and cellular pharmacology
JD Moore, A Potter
Bioorganic & medicinal chemistry letters 23 (15), 4283-4291, 2013
1192013
Review Article: The pre-chorismate (shikimate) and quinate pathways in filamentous fungi: theoretical and practical aspects
AR Hawkins, HK Lamb, JD Moore, IG Charles, CF Roberts
Journal of general microbiology 139 (12), 2891-2899, 1993
1061993
Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution
A Potter, V Oldfield, C Nunns, C Fromont, S Ray, CJ Northfield, CJ Bryant, ...
Bioorganic & medicinal chemistry letters 20 (22), 6483-6488, 2010
1002010
Triazolo [1, 5-a] pyrimidines as novel CDK2 inhibitors: protein structure-guided design and SAR
CM Richardson, DS Williamson, MJ Parratt, J Borgognoni, AD Cansfield, ...
Bioorganic & medicinal chemistry letters 16 (5), 1353-1357, 2006
972006
Synthetic lethal targeting of ARID1A-mutant ovarian clear cell tumors with dasatinib
RE Miller, R Brough, I Bajrami, CT Williamson, S McDade, J Campbell, ...
Molecular cancer therapeutics, 2016
952016
Structure-guided design of pyrazolo [1, 5-a] pyrimidines as inhibitors of human cyclin-dependent kinase 2
DS Williamson, MJ Parratt, JF Bower, JD Moore, CM Richardson, ...
Bioorganic & medicinal chemistry letters 15 (4), 863-867, 2005
952005
Structure-guided design of α-amino acid-derived Pin1 inhibitors
AJ Potter, S Ray, L Gueritz, CL Nunns, CJ Bryant, SF Scrace, ...
Bioorganic & medicinal chemistry letters 20 (2), 586-590, 2010
942010
Structure-guided design of α-amino acid-derived Pin1 inhibitors
AJ Potter, S Ray, L Gueritz, CL Nunns, CJ Bryant, SF Scrace, ...
Bioorganic & medicinal chemistry letters 20 (2), 586-590, 2010
942010
The impact of CRISPR–Cas9 on target identification and validation
JD Moore
Drug discovery today 20 (4), 450-457, 2015
702015
Fragment screening by weak affinity chromatography: comparison with established techniques for screening against HSP90
E Meiby, H Simmonite, L le Strat, B Davis, N Matassova, JD Moore, ...
Analytical chemistry 85 (14), 6756-6766, 2013
702013
Identification of the Nuclear Localization Signal inXenopus Cyclin E and Analysis of Its Role in Replication and Mitosis
JD Moore, S Kornbluth, T Hunt
Molecular biology of the cell 13 (12), 4388-4400, 2002
622002
Discovery of a potent CDK2 inhibitor with a novel binding mode, using virtual screening and initial, structure-guided lead scoping
CM Richardson, CL Nunns, DS Williamson, MJ Parratt, P Dokurno, ...
Bioorganic & medicinal chemistry letters 17 (14), 3880-3885, 2007
572007
Dual direction CRISPR transcriptional regulation screening uncovers gene networks driving drug resistance
C Sage, S Lawo, P Panicker, TME Scales, SA Rahman, AS Little, ...
Scientific reports 7 (1), 17693, 2017
522017
VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells
JD Moore, A Staniszewska, T Shaw, J D'Alessandro, B Davis, A Surgenor, ...
Oncotarget 5 (24), 12862, 2014
502014
The system can't perform the operation now. Try again later.
Articles 1–20